CI
ACLS icon

Corient IA’s Axcelis ACLS Stock Holding History

Corient IA’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465K Buy
+5,000
New +$443K 0.44% 66

Other funds holding ACLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Corient IA's ACLS Position: Q1 2026 in Review

Corient IA opened a new position in Axcelis (ACLS) in Q1 2026: 5,000 shares worth $465K. The stake represents 0.44% of the portfolio and ranks #66 among its holdings.

377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Corient IA held 5,000 shares of Axcelis worth $465K as of Q1 2026.
  • Axcelis was a new Corient IA position in Q1 2026.
  • Axcelis made up 0.44% of Corient IA's portfolio in Q1 2026, its #66 holding.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.